Yukun Wang

Yukun Wang

Auto-generated profile, based on publicly available information

Yukun Wang

Department of Orthopedic, Spinal Pain Research Institute, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China; School of Medicine, Tongji University, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2023 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
BSBinay Kumar Shah
Binay Kumar Shah
BSBivek Singh
Bivek Singh
YWYukun Wang
Yukun Wang
SXShuanshuan Xie
Shuanshuan Xie
CWChanghui Wang
Changhui Wang
Most patients diagnosed with chronic obstructive pulmonary disease (COPD) present with hallmark features of airway mucus hypersecretion, including cough and expectoration. Airway mucus function as a native immune system of the lung that severs to trap particulate matter and pathogens and allows them to clear from the lung via cough and ciliary transport. Chronic mucus hypersecretion (CMH) is the main factor contributing to the increased risk of morbidity and mortality in specific subsets of COPD patients. It is, therefore, primarily important to develop medications that suppress mucus hypersecretions in these patients. Although there have been some advances in COPD treatment, more work remains to be done to better understand the mechanism underlying airway mucus hypersecretion and seek more effective treatments. This review article discusses the structure and significance of mucus in the lungs focusing on gel-forming mucins and the impacts of CMH in the lungs. Furthermore, we summarize the article with pharmacological and nonpharmacological treatments as well as novel and interventional procedures to control CMH in COPD patients.

9 October 2025 in International Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
FLFurui Liu
Furui Liu
YWYukun Wang
Yukun Wang
HYHuang Yan
Huang Yan
YFYunshan Fan
Yunshan Fan
SHShisheng He
Shisheng He
Background: The Uni-portal Bi-channel & Dual-media Spinal Endoscope (UBD) is a recently developed, minimally invasive spinal endoscopic technique. This article reviews the mechanism, clinical manifestations, diagnosis, treatment, and prevention of UBD-induced myeloid hypertension-like syndrome (MHI). Case presentation: A 44-year-old man was admitted for low back pain lasting >2 years and progressive left-leg pain for 3 months. Under general anaesthesia, L5/S1 discectomy was performed via an interlaminar approach using the UBD system. Fifteen minutes after extubation he developed head-and-neck and low-back pain, lower-limb numbness, immobility, and agitation. Intravenous midazolam 5 mg, dexmedetomidine 1 μg/kg, methylprednisolone sodium succinate, and mannitol were given for sedation and oedema control. Within 1 h the symptoms improved; they resolved completely after 3 h. Twelve hours post-operatively VAS scores were 1 for low back pain and 0 for leg pain. One month later both VAS scores were 0 and the patient reported no dizziness. Conclusions: MHI is a rare but potentially serious complication of water-medium spinal endoscopy. Prevention, early recognition, and prompt symptomatic and supportive care usually produce symptom relief within 1 h and complete resolution within 24 h. The UBD technique, which allows switching between air and water media, appears effective in preventing and treating MHI.